Aegis Capital Invests in SuppMatch – AI-Powered Evidence-Based Supplementation Guidance
The globaldietary supplements market continues to expand at a rapid pace, driven bygrowing health awareness, aging populations, and the increasing focus onpreventive healthcare. According to market forecasts, the European supplementsmarket is expected to grow from USD 45.6 billion in 2024 to USD 93.2 billionby 2033, representing a compound annual growth rate (CAGR) of 8.3%.In the United States, the market is projected to reach USD 68.7 billion in2025 and expand to USD 131.1 billion by 2033 (CAGR 8.5%). In Poland,the market is already valued at more than PLN 7 billion, growing atapproximately 10% annually, with forecasts indicating continued annualgrowth of 7–9% between 2025 and 2027.
This rapidexpansion has resulted in an overwhelming number of products and informationsources, making it increasingly difficult for consumers to distinguishevidence-based recommendations from marketing claims and short-lived socialmedia trends.
Thechallenge is further amplified by tightening regulations governing marketingcommunication and the lack of standardized information on supplementformulations, dosages, ingredient forms, and quality. As a result, makinginformed purchasing decisions has become increasingly difficult for bothconsumers and online retailers.
At the sametime, online sales have become the fastest-growing distribution channel withinthe supplements industry. Across Europe, the Health & Beauty e-commercesegment is expanding at a 9.8% CAGR, with an estimated market value ofapproximately EUR 10 billion. Nearly 16% of internet users in theEuropean Union have purchased dietary supplements online. In Poland,e-commerce's share of the Health category has increased from 18% in 2020 tonearly 30% in 2024–2025, with online supplement sales estimated at PLN2.1–2.6 billion.
Anothergrowing challenge is consumer safety. As populations age and polypharmacy—theconcurrent use of multiple medications and supplements—becomes more common, therisk of interactions between dietary supplements and prescription drugscontinues to increase. Despite its importance, this issue remains largelyunaddressed by existing digital solutions.
SuppMatchwas created to address these structural challenges. The company has developedan AI-powered assistant that supports supplement selection based onevidence-based medicine. Trained on peer-reviewed scientific publications,systematic reviews, and meta-analyses, the platform standardizes complexsupplement data and provides consumers with reliable, science-backedrecommendations. At the same time, it integrates user profiles with merchants'product catalogs and real-time inventory, enabling e-commerce businesses toimprove conversion rates, increase basket value, and strengthen customer trust.
Thecompany's initial go-to-market strategy focuses on integrations with e-commerceplatforms operating in the Health & Wellness, Pharmacy, and SportsNutrition segments. Future development plans include incorporating wearabledevice data and nutrigenomics to deliver fully personalized health journeys.
Aegis Capital has invested in SuppMatch to support the development of a technology addressingone of the most significant challenges at the intersection of digital healthand e-commerce.
Theinvestment reflects the company's potential to establish a new category ofintelligent decision-support solutions for dietary supplementation. Bycombining artificial intelligence, evidence-based scientific knowledge, andseamless e-commerce integration, SuppMatch has built a scalable business modelpositioned to capitalize on the continued growth of the global Health &Wellness market.
